Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AK Other drugs for treatment of tuberculosis
J04AK08 Pretomanid
D10722 Pretomanid (USAN/INN) <US>
USP drug classification [BR:br08302]
Antimycobacterials
Antituberculars
Pretomanid
D10722 Pretomanid (USAN/INN)
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
D10722 Pretomanid
Antimicrobials [BR:br08307]
Antibacterials
Other antibacterials
Mycolic acid biosynthesis inhibitor
D10722 Pretomanid (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10722
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10722
Other DBs
CAS:
187235-37-6
PubChem:
254741683
KCF data
ATOM 25
1 N2b N 7.2800 -16.4500 #+
2 O3a O 7.2800 -17.8500
3 O3a O 6.0676 -15.7500 #-
4 C8y C 8.3399 -15.7401
5 C8x C 9.6483 -16.2211
6 N4y N 10.5102 -15.1254
7 C8y C 9.7345 -13.9672
8 N5x N 8.3932 -14.3470
9 C1x C 11.9071 -15.0324
10 C1y C 12.5250 -13.7761
11 C1x C 11.7492 -12.6178
12 O2x O 10.3523 -12.7109
13 O2a O 13.9250 -13.7761
14 C1b C 14.6250 -14.9885
15 C8y C 16.0250 -14.9885
16 C8x C 16.7225 -16.1967
17 C8x C 18.1225 -16.1967
18 C8y C 18.8225 -14.9842
19 C8x C 18.1249 -13.7760
20 C8x C 16.7249 -13.7761
21 O2a O 20.2225 -14.9842
22 C1d C 20.9225 -16.1967
23 X F 21.6225 -17.4091
24 X F 22.1350 -15.4967
25 X F 19.7101 -16.8967
BOND 27
1 1 2 2
2 1 3 1
3 1 4 1
4 4 5 2
5 5 6 1
6 6 7 1
7 7 8 2
8 4 8 1
9 6 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 7 12 1
14 10 13 1 #Up
15 13 14 1
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 15 20 1
23 18 21 1
24 21 22 1
25 22 23 1
26 22 24 1
27 22 25 1